1、BSI Standards PublicationWB11885_BSI_StandardCovs_2013_AW.indd 1 15/05/2013 15:06Guidance on the relationship between EN ISO 13485: 2016 (Medical devices Quality management systems Requirements for regulatory purposes) and European Medical Devices Regulation and In Vitro Diagnostic Medical Devices R
2、egulationPD CEN/TR 17223:2018TECHNICAL REPORT RAPPORT TECHNIQUE TECHNISCHER BERICHT CEN/TR 17223 March 2018 ICS 03.100.70; 11.040.01English versionGuidance on the relationship between EN ISO 13485: 2016 (Medical devices - Quality management systems - Requirements for regulatory purposes) and Europea
3、n Medical Devices Regulation and In Vitro Diagnostic Medical Devices Regulation Document dorientation sur la relation entre lEN ISO13485: 2016 (Dispositifs mdicaux - Systmes de management de la qualit - Exigences des finsrglementaires) et le Rglement europen relatif auxdispositifs mdicaux ainsi que
4、le Rglement relatif auxdispositifs mdicaux de diagnostic in vitro Leitfaden zum Zusammenhang zwischen EN ISO13485: 2016 (Medizinprodukte - Qualittsmanagementsysteme - Anforderungen frregulatorische Zwecke) und den europischen Verordnungen ber Medizinprodukte und In-vitro-Diagnostika This Technical R
5、eport was approved by CEN on 12 February 2018. It has been drawn up by the Technical Committee CEN/CLC/JTC 3.CEN and CENELEC members are the national standards bodies and national electrotechnical committees of Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, F
6、ormer Yugoslav Republic of Macedonia, France, Germany,Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey and United Kingdom.CEN-CENELEC Management Centre:Rue de
7、 la Science 23, B-1040 Brussels 2018 CEN/CENELEC All rights of exploitation in any form and by any means reserved worldwide for CEN national Members and forCENELEC Members.Ref. No. CEN/TR 17223:2018 ENational forewordThis Published Document is the UK implementation of CEN/TR 17223:2018.The UK partic
8、ipation in its preparation was entrusted to Technical Committee CH/210, Quality management and corresponding general aspects for medical devices.A list of organizations represented on this committee can be obtained on request to its secretary.This publication does not purport to include all the nece
9、ssary provisions of a contract. Users are responsible for its correct application. The British Standards Institution 2018 Published by BSI Standards Limited 2018ISBN 978 0 580 51912 3ICS 03.100.70; 11.040.01Compliance with a British Standard cannot confer immunity from legal obligations.This Publish
10、ed Document was published under the authority of the Standards Policy and Strategy Committee on 31 March 2018.Amendments/corrigenda issued since publicationDate Text affectedPUBLISHED DOCUMENTPD CEN/TR 17223:2018TECHNICAL REPORT RAPPORT TECHNIQUE TECHNISCHER BERICHT CEN/TR 17223 March 2018 ICS 03.10
11、0.70; 11.040.01 English version Guidance on the relationship between EN ISO 13485: 2016 (Medical devices - Quality management systems - Requirements for regulatory purposes) and European Medical Devices Regulation and In Vitro Diagnostic Medical Devices Regulation Document dorientation sur la relati
12、on entre lEN ISO 13485: 2016 (Dispositifs mdicaux - Systmes de management de la qualit - Exigences des fins rglementaires) et le Rglement europen relatif aux dispositifs mdicaux ainsi que le Rglement relatif aux dispositifs mdicaux de diagnostic in vitro Leitfaden zum Zusammenhang zwischen EN ISO 13
13、485: 2016 (Medizinprodukte - Qualittsmanagementsysteme - Anforderungen fr regulatorische Zwecke) und den europischen Verordnungen ber Medizinprodukte und In-vitro-Diagnostika This Technical Report was approved by CEN on 12 February 2018. It has been drawn up by the Technical Committee CEN/CLC/JTC 3.
14、 CEN and CENELEC members are the national standards bodies and national electrotechnical committees of Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, Former Yugoslav Republic of Macedonia, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lit
15、huania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey and United Kingdom. CEN-CENELEC Management Centre: Rue de la Science 23, B-1040 Brussels 2018 CEN/CENELEC All rights of exploitation in any form and by any means
16、reserved worldwide for CEN national Members and for CENELEC Members. Ref. No. CEN/TR 17223:2018 EPD CEN/TR 17223:2018CEN/TR 17223:2018 (E) 2 Contents Page European Foreword . 3 Introduction . 4 1 Scope . 7 2 Normative references. 7 3 Terms and definitions 7 4 Relationship between the European Regula
17、tions for Medical Devices and in vitro Diagnostic Medical Devices and the clauses of EN ISO 13485 . 7 PD CEN/TR 17223:2018CEN/TR 17223:2018 (E) 3 European Foreword This document (CEN/TR 17223:2018) has been prepared by Technical Committee CEN/CLC/JTC 3, “Quality management and corresponding general
18、aspects for medical devices”, the secretariat of which is held by NEN. Attention is drawn to the possibility that some of the elements of this document may be the subject of patent rights. CEN shall not be held responsible for identifying any or all such patent rights. PD CEN/TR 17223:2018CEN/TR 172
19、23:2018 (E) 4 Introduction This Technical Report has been prepared to provide guidance on the relationship between EN ISO 13485:2016 (Medical devices Quality management systems Requirements for regulatory purposes) and the requirements in the European Regulations on Medical Devices (MDR)- Regulation
20、 (EU) 2017/745 - and in vitro Diagnostic Medical Devices (IVDR) -Regulation (EU) 2017/746. EN ISO 13485 describes a quality management system that is applicable to medical devices and is intended for regulatory purposes. The European Regulations for medical devices and EN ISO 13485 present holistic
21、requirements for systematic application of a process approach to quality management into which an organization can incorporate regulatory requirements that are applicable to its activities. As the requirements are integrated and build on each other, all the requirements applicable to the organizatio
22、ns activities and the applicable regulatory requirements need to be applied. It is not intended that requirements are implemented in isolation from the complete system. While this Technical Report describes the interrelationship of individual paragraphs, or parts of a paragraph, of the Regulations w
23、ith particular subclauses of EN ISO 13485, this is not intended to imply that these subclauses can be implemented in the absence of the entire quality management system described in the standard. This Technical Report focuses on the general obligations of the manufacturer (Article 10) and the confor
24、mity assessment requirements (Annexes IX and XI) of the European Regulations for Medical Devices and in vitro Diagnostic Medical Devices. Compliance with all the normative clauses in EN ISO 13485 will ensure that a process is in place to address quality management system aspects related to medical d
25、evices, which are included in Article 10 and Annexes IX and XI of the Regulations. Generally, it is not meaningful to link individual clauses of EN ISO 13485 to specific general safety and performance requirements (Annex I). The General Requirements in Chapter 1 of Annex 1, however, relate to the ap
26、plication of risk and the requirements for the manufacturer to implement a risk management system. As the general obligation of the manufacturer in Article 10 requires the implementation of a risk management system and EN ISO 13485 requires processes for risk management in product realization, the r
27、elationships between Chapter 1 in the general safety and performance requirements and the corresponding subclauses of EN ISO 13485:2016 are included in this Technical Report. Specific details of a risk management system for medical devices are provided in EN ISO 14971. The scope of EN ISO 13485 indi
28、cates that the standard can be applied by: organizations involved in one or more stages of the life-cycle, including design and development, production, storage and distribution, installation, or servicing of a medical device and design and development or provision of associated activities (e.g. tec
29、hnical support), and suppliers or external parties that provide product, including quality management system-related services, to such organizations. As such, EN ISO 13485 may be applied by other economic operators in the supply chain such as authorized representatives, importers, distributors or as
30、semblers of systems or procedure packs. Consequently, EN ISO 13485 can also support meeting the regulatory obligations for authorized representatives (Article 11), Importers (Article 13), Distributors (Article 14) or assemblers of systems or procedure packs (MDR Article 22). PD CEN/TR 17223:2018CEN/
31、TR 17223:2018 (E) 5 However, because this is an adoption of an international standard, intended to be applicable in jurisdictions all over the world, it is not the primary goal of the standard to cover exactly the European quality management system requirements. Therefore, for all of the quality man
32、agement system requirements, conformity is not entirely achieved by complying only with the requirements specified in EN ISO 13485. Manufacturers and conformity assessment bodies will need to feed the quality management system requirements in the applicable European Regulation into the processes pro
33、vided by EN ISO 13485. For example, Article 15 of the European Regulations define specific requirements for a position of person responsible for regulatory compliance. While this position is not explicitly mentioned in EN ISO 13485, it constitutes a regulatory requirement that would need to be incor
34、porated into the quality management system of an organization seeking to comply with the Regulations. Once incorporated into the quality management system, related requirements, for example for competence, definition of responsibilities and interrelationships, would apply to this position. In additi
35、on, the European Regulations require the incorporation of certain processes in the quality management system, such as clinical evaluation, risk management, post-market surveillance, and assignment of unique device identification. EN ISO 13485 requires the integration of these processes into the qual
36、ity management system in accordance with regulatory requirements but does not explicitly include the details of the particular European Union regulatory requirements within the standard. Explanation on the relationship between the requirements of EN ISO 13485 and: European Regulations on Medical Dev
37、ices (Regulation (EU) 2017/745) is provided in this Technical Report in Table 1; and, European Regulations on in vitro Diagnostic Medical Devices (Regulation (EU) 2017/746) is provided in this Technical Report in Table 2. NOTE 1 When a requirement does not appear in Table 1 or Table 2, it means that
38、 it is not addressed by EN ISO 13485:2016. In addition to requirements on the manufacturers quality management system, Article 10 and Annexes IX and XI of the European Regulations include a description of the regulatory processes and activities undertaken by the notified body, competent authority an
39、d European Commission, which are outside of the scope of EN ISO 13485 and therefore not covered by the standard. NOTE 2 In many places, Annex XI of the European regulations refers back to paragraphs in Annex IX. In Tables 1 and 2, the applicable text from Annex IX is incorporated under the reference
40、 for Annex XI. Article 8 of the European Regulations (Use of harmonized standards), indicates that system or process requirements to be fulfilled by economic operators, such as requirements for quality management systems, are to be presumed to be fulfilled if the system or process is in conformance
41、with a relevant harmonized standard. A standard is given the status of being harmonized by publication of a reference in the Official Journal of the European Union under European Regulations for Medical Devices and in vitro Diagnostic Medical Devices. For a harmonized standard, presumption of confor
42、mity with the identified requirements of these Regulations is provided by compliance with the normative clauses given in the table or tables in the Annex Z of a standard, within the limits of the scope of the standard, once that standard has been implemented as a national standard in at least one Me
43、mber State. The Annex Z explains to which requirements, under PD CEN/TR 17223:2018CEN/TR 17223:2018 (E) 6 which conditions and to what extent, presumption of conformity can be claimed. Inclusion of a standard the Official Journal of the European Union and the preparation, agreement and publication o
44、f an Annex Z requires a mandate being given to a European Standards Body by the European Commission. In advance of such a mandate, this Technical Report has been prepared to provide guidance to manufacturers and conformity assessment bodies on the relationship between EN ISO 13485:2016 and the Europ
45、ean Regulations for Medical Devices and in vitro Diagnostic Medical Devices. This Technical Report does not imply that compliance with EN ISO 13485 provides a presumption of conformity with the requirements of the European Regulations for Medical Devices or in vitro Diagnostic Medical Devices. PD CE
46、N/TR 17223:2018CEN/TR 17223:2018 (E) 7 1 Scope This Technical Report provides guidance on the relationship between EN ISO 13485:2016, Medical devices Quality management systems Requirements for regulatory purposes and the requirements in EU Regulation 2017/745 on Medical Devices and EU Regulation 20
47、17/746 on in vitro Diagnostic Medical Devices. 2 Normative references The following referenced document is indispensable for the application of this document. For dated references, only the edition cited applies. For undated references, the latest edition of the referenced document (including any am
48、endments) applies. EN ISO 13485:2016, Medical devices - Quality management systems - Requirements for regulatory purposes (ISO 13485:2016) 3 Terms and definitions For the purposes of this Technical Report, the terms and definitions in EN ISO 13485 apply. 4 Relationship between the European Regulatio
49、ns for Medical Devices and in vitro Diagnostic Medical Devices and the clauses of EN ISO 13485 Table 1 shows the relationship between the clauses of EN ISO 13485 and the requirements of the European Regulations on Medical Devices (Regulation (EU) 2017/745), together with commentary on the extent to which the requirements of the standard cover the specific details in the Regulation. Table 2 shows the relationship between the clauses of EN ISO 13485 and the requirements of the European Regulations on in vitro Diagnostic Medical Dev
